35 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Author: Lisa Levin | February 18, 2020 09:25am

Gainers

Stealth BioTherapeutics, Inc. (NASDAQ:MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H.C. Wainwright, on December 23, the current rating is at Neutral.
Viveve Medical, Inc. (NASDAQ:VIVE) shares increased by 17.8% to $1.39. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
Brickell Biotech, Inc. (NASDAQ:BBI) shares surged 17.2% to $1.36.
InMode, Inc. (NASDAQ:INMD) stock moved upwards by 7.1% to $47.10. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
Aytu BioScience, Inc. (NASDAQ:AYTU) shares increased by 6.2% to $0.84.
CannTrust Holdings, Inc. (NYSE:CTST) stock surged 5.7% to $0.87.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares rose 5.7% to $2.99. The most recent rating by B. Riley FBR, on December 27, is at Buy, with a price target of $11.00.
Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares surged 5.3% to $0.98.
Ardelyx, Inc. (NASDAQ:ARDX) shares rose 4.9% to $7.55. The most recent rating by Citigroup, on February 12, is at Buy, with a price target of $13.00.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares increased by 4.8% to $4.35. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) stock rose 4.5% to $4.18. The most recent rating by Piper Sandler, on February 18, is at Overweight, with a price target of $12.00.
Genprex, Inc. (NASDAQ:GNPX) stock surged 4.4% to $4.47.
Aptevo Therapeutics, Inc. (NASDAQ:APVO) stock increased by 4.2% to $0.50.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares moved upwards by 4.1% to $3.05. The most recent rating by Roth Capital, on January 21, is at Buy, with a price target of $10.00.
ADMA Biologics, Inc. (NASDAQ:ADMA) shares rose 4.0% to $3.65.
Moleculin Biotech, Inc. (NASDAQ:MBRX) stock surged 3.9% to $0.79.
TG Therapeutics, Inc. (NASDAQ:TGTX) shares moved upwards by 3.9% to $16.40. The most recent rating by H.C. Wainwright, on January 17, is at Buy, with a price target of $24.00.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) shares increased by 3.6% to $38.30. The most recent rating by SunTrust Robinson Humphrey, on February 14, is at Buy, with a price target of $150.00.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares moved upwards by 3.6% to $2.90.
Mustang Bio, Inc. (NASDAQ:MBIO) stock rose 3.5% to $3.89.
Biogen, Inc. (NASDAQ:BIIB) shares rose 3.3% to $344.00. The most recent rating by Nomura, on February 07, is at Buy, with a price target of $392.00.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) stock surged 3.2% to $6.76. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $25.00.
Novavax, Inc. (NASDAQ:NVAX) stock moved upwards by 3.1% to $7.92.
Oncolytics Biotech, Inc. (NASDAQ:ONCY) stock increased by 3.1% to $2.67.
SmileDirectClub, Inc. (NASDAQ:SDC) shares moved upwards by 3.0% to $13.22. The most recent rating by Wolfe Research, on January 09, is at Underperform, with a price target of $7.00.

Losers

Lianluo Smart, Inc. (NASDAQ:LLIT) shares fell 5.0% to $0.96 during Tuesday's pre-market session.
Avinger, Inc. (NASDAQ:AVGR) stock fell 4.7% to $0.59.
Bruker, Inc. (NASDAQ:BRKR) shares plummeted 4.0% to $48.50. The most recent rating by Wells Fargo, on January 08, is at Overweight, with a price target of $60.00.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock decreased by 3.9% to $2.00.
Intec Pharma, Inc. (NASDAQ:NTEC) shares decreased by 3.7% to $0.27.
Sundial Growers, Inc. (NASDAQ:SNDL) shares fell 3.7% to $1.30. According to the most recent rating by CIBC, on January 31, the current rating is at Underperformer.
Agile Therapeutics, Inc. (NASDAQ:AGRX) shares declined 3.7% to $3.92.
HEXO, Inc. (NYSE:HEXO) shares plummeted 3.3% to $1.46.
VBI Vaccines, Inc. (NASDAQ:VBIV) stock decreased by 3.3% to $1.48.
Brainstorm Cell, Inc. (NASDAQ:BCLI) shares declined 3.1% to $5.00.